We are thrilled to announce our participation at the European Stroke Organisation Conference (ESOC) from 21ˢᵗ to 23ʳᵈ May 2025 in Helsinki, Finland.

Last weekend, Moleac hosted a Scientific Conference in Bali in collaboration with our Indonesian partner, Ferron PT Pharmaceuticals.

Last weekend, Moleac held the Scientific Conference in Kotor, Montenegro, focusing on the integration of natural therapies in neurological care, covering key insights into stroke and Alzheimer’s disease.

This week is Earth Day! Moleac is proud to support Seacology (www.seacology.org) in their efforts to protect our planet and empower communities.

📰🧠🔬 POST-STROKE STUDY HIGHLIGHTS – Post-stroke cognitive impairment and dementia research in Southeast Asia (SEA): A scoping review by Mtambo, M. L., Ragunathan, T., Mohan, D., Warren, N., Su, T. T., & Quek, K. F.

Last week in Vienna, alongside the Alzheimer’s and Parkinson’s Diseases (AD/PD) 2025 Conference, we had the pleasure of hosting our symposium “Expanding Horizons for Alzheimer’s Disease Management.”

Moleac is proud to partner with Kythe Foundation Inc., www.kythe.org, a remarkable organization in the Philippines that supports over 18,000 hospitalized children battling cancer and chronic illnesses.

Our team is at the AD/PD International Conference in Vienna!

📰🧠🔬 TRAUMATIC BRAIN INJURY (TBI) STUDY HIGHLIGHTS – Longitudinal healthcare use after pediatric brain injury: A population-based birth cohort study by Chan V, Wirianto CS, Balogh R, Escobar MD.

Moleac will be attending the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD) from April 1ˢᵗ to 5ᵗʰ, 2025, in Vienna.

Closing a Successful Affiliates Convention in France! Last week, we had the pleasure of welcoming our commercial partners from over 15 countries for an engaging day of discussions and strategic alignment.

March is Brain Injury Awareness Month! Each year, 69 million people worldwide suffer a traumatic brain injury (TBI), with severe cases leading to long-term disability in up to 50% of cases.